Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tacrine]

C Dávila1, C Viteri, P de Castro

  • 1Departamento de Neurología y Neurocirugía y Neurocirugía, Facultad de Medicina, Universidad de Navarra.

Revista De Medicina De La Universidad De Navarra
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low red:far-red light ratios reduce the content of major sesquiterpenes in type VI trichomes of Solanum habrochaites and increase plant attractiveness to Tuta absoluta females.

Annals of botany·2025
Same author

Longitudinal profiling of human androgenotes through single-cell analysis unveils paternal gene expression dynamics in early embryo development.

Human reproduction (Oxford, England)·2024
Same author

The health equity in all policies (HEiAP) approach before and beyond the Covid-19 pandemic in the Italian context.

International journal for equity in health·2020
Same author

"It Ruined My Life": The effects of the War on Drugs on people who inject drugs (PWID) in rural Puerto Rico.

The International journal on drug policy·2017
Same author

EPICON consensus: recommendations for proper management of switching to eslicarbazepine acetate in epilepsy.

Neurologia·2016
Same author

Cerebrospinal fluid synaptic proteins as useful biomarkers in tyrosine hydroxylase deficiency.

Molecular genetics and metabolism·2014
Same journal

[The interests of the medical class].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Treatment to conserve fertility in a patient diagnosed with deep pelvic endometriosis].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Treatment for endometriosis].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Basic research into endometriosis. Are we going in the right direction?].

Revista de medicina de la Universidad de Navarra·2009
Same journal

[Diagnosis of endometriosis].

Revista de medicina de la Universidad de Navarra·2009
Same journal

Ultrasound study of the myoendometrial border.

Revista de medicina de la Universidad de Navarra·2009
See all related articles

Alzheimer's disease (AD) involves changes in brain acetylcholine. Tacrine, an acetylcholinesterase inhibitor, showed promise in improving memory for mild to moderate AD patients.

Area of Science:

  • Neuroscience
  • Pharmacology

Context:

  • Alzheimer's disease (AD) is characterized by significant alterations in cholinergic neurotransmission.
  • Degeneration of presynaptic cholinergic neurons is a key feature, leading to a deficit in acetylcholine.
  • The cholinergic hypothesis suggests restoring acetylcholine levels could alleviate cognitive decline in AD.

Purpose:

  • To explore the role of cholinergic neurotransmission in Alzheimer's disease.
  • To evaluate tacrine as a potential therapeutic agent for AD based on the cholinergic hypothesis.

Summary:

  • Tacrine, a tetrahydroaminoacridine, is an acetylcholinesterase inhibitor investigated for AD treatment.
  • Clinical trials indicated tacrine can positively impact memory in patients with mild to moderate AD symptoms.
  • Despite some inconsistent results attributed to methodological variations, tacrine was introduced as an initial palliative therapy for AD.

Related Experiment Videos

Impact:

  • The cholinergic hypothesis, though not fully encompassing AD's complexity, has guided therapeutic strategies.
  • Tacrine represents a significant step in developing palliative treatments for Alzheimer's disease.
  • This research highlights the importance of targeting neurotransmitter systems for cognitive disorders.